{"doi":"10.3390/jcm11226648","title":"Patients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders","abstract":"<jats:p>Comorbidity of substance use disorders (SUD) and severe mental illness (SMI) is highly frequent in patients, the most common diagnoses being schizophrenia (SZ), bipolar disorder (BD) and major depressive disorder (MDD). Since comorbidity has its own clinical features, and neurocognitive functioning is not always similar to psychiatric symptoms the present study explores the cognitive performance of patients with dual disorders. A neuropsychological battery of tests was used to assess 120 under treatment male patients, 40 for each group considered (SZ + SUD, BD + SUD and MDD + SUD) who were mainly polyconsumers. Significant differences (with premorbid IQ as a covariate) were found among the groups, with SZ + SUD having a worse performance in attention, verbal learning, short term memory and recognition. The consideration of a global Z score for performance evidenced an impaired neurocognitive pattern for SZ + SUD compared with BD + SUD and MDD + SUD. According to norms, all patients showed difficulties in verbal learning, short-term memory and recognition. Our research indicated that the neurocognitive functioning of dual disorder patients was influenced by the comorbid SMI, with SZ + SUD presenting major difficulties. Future studies should thoroughly explore the role of such difficulties as indicators or endophenotypes for dual schizophrenia disorders, and their usefulness for prevention and treatment.</jats:p>","journal":"Journal of Clinical Medicine","year":2022,"id":638244,"datarank":0.3596842909197557,"base_score":2.3978952727983707,"endowment":2.3978952727983707,"self_citation_contribution":0.3596842909197557,"citation_network_contribution":0.0,"self_endowment_contribution":0.3596842909197557,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":10,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1657618,"name":"Alvaro Gonzalez-Sanchez","orcid":"0000-0001-5971-6669","position":1,"is_corresponding":false},{"id":1657620,"name":"José Francisco Navarro","orcid":"0000-0002-5104-8974","position":2,"is_corresponding":false},{"id":1084849,"name":"Rafael Penadés","orcid":"0000-0002-1564-3717","position":3,"is_corresponding":false},{"id":1657623,"name":"Ana Adan","orcid":"0000-0002-3328-3452","position":4,"is_corresponding":false},{"id":1657617,"name":"Julia E. Marquez-Arrico","orcid":"0000-0003-0076-1056","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Patients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders","abstract":"<jats:p>Comorbidity of substance use disorders (SUD) and severe mental illness (SMI) is highly frequent in patients, the most common diagnoses being schizophrenia (SZ), bipolar disorder (BD) and major depressive disorder (MDD). Since comorbidity has its own clinical features, and neurocognitive functioning is not always similar to psychiatric symptoms the present study explores the cognitive performance of patients with dual disorders. A neuropsychological battery of tests was used to assess 120 under treatment male patients, 40 for each group considered (SZ + SUD, BD + SUD and MDD + SUD) who were mainly polyconsumers. Significant differences (with premorbid IQ as a covariate) were found among the groups, with SZ + SUD having a worse performance in attention, verbal learning, short term memory and recognition. The consideration of a global Z score for performance evidenced an impaired neurocognitive pattern for SZ + SUD compared with BD + SUD and MDD + SUD. According to norms, all patients showed difficulties in verbal learning, short-term memory and recognition. Our research indicated that the neurocognitive functioning of dual disorder patients was influenced by the comorbid SMI, with SZ + SUD presenting major difficulties. Future studies should thoroughly explore the role of such difficulties as indicators or endophenotypes for dual schizophrenia disorders, and their usefulness for prevention and treatment.</jats:p>","is_dataset_classified":null,"base_score":2.3978952727983707,"endowment":2.3978952727983707,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36431125","pmcid":"PMC9698443","openalex_id":"https://openalex.org/W4308866558","authors":[],"funders":[{"funder_name":"Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033)","grant_id":"PID2020-117767GB-I00","title":null},{"funder_name":"Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033)","grant_id":"2017SGR-748","title":null}],"total_grants":2,"fwci":1.4105,"citation_percentile":0.81286796,"influential_citations":0,"citation_trend":[{"year":2023,"count":5},{"year":2024,"count":3},{"year":2025,"count":2}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.mdpi.com/2077-0383/11/22/6648/pdf?version=1668588801","host_type":"journal"},{"url":"https://www.mdpi.com/2077-0383/11/22/6648/pdf?version=1668588801","host_type":"publisher"},{"url":"https://www.mdpi.com/2077-0383/11/22/6648/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3390/jcm11226648","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36431125","host_type":"repository"},{"url":"https://doaj.org/article/069c3db6c27e49579bfb47399ef2641f","host_type":"repository"},{"url":"https://dx.doi.org/10.3390/jcm11226648","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9698443","host_type":"repository"},{"url":"https://hdl.handle.net/10630/25887","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC9698443","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC9698443?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Bipolar Disorder and Treatment","Schizophrenia research and treatment","Treatment of Major Depression"],"mesh_terms":[],"keywords":["Neurocognitive","Schizophrenia (object-oriented programming)","Bipolar disorder","Medicine","Psychiatry","Major depressive disorder","Comorbidity","Dual diagnosis","Clinical psychology","Neuropsychology","Substance abuse","Endophenotype","Verbal memory","Cognition","Schizophrenia","Substance Use Disorders","Neurocognition","Bipolar Disorders","Major Depressive Disorders","Dual Disorders"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-06T20:21:41.433886Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}